Skip to main content
Have a personal or library account? Click to login
Plasma BDNF levels in children with ADHD before and after methylphenidate treatment Cover

Plasma BDNF levels in children with ADHD before and after methylphenidate treatment

Open Access
|May 2026

References

  1. Cortese S, Song M, Farhat LC, Yon DK, Lee SW, Kim MS, et al. Incidence, prevalence, and global burden of ADHD from 1990 to 2019 across 204 countries: data, with critical re-analysis, from the Global Burden of Disease study. Mol Psychiatry. 2023 Sep 8;1–8. doi:10.1038/s41380-023-02228-3
  2. Polanczyk GV, Salum GA, Sugaya LS, Caye A, Rohde LA. Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry. 2015 Mar;56(3):345–65. doi:10.1111/jcpp.12381 PubMed PMID: 25649325.
  3. Mitre M, Mariga A, Chao MV. Neurotrophin signalling: novel insights into mechanisms and pathophysiology. Clin Sci (Lond). 2017 Jan 1;131(1):13–23. doi:10.1042/CS20160044 PubMed PMID: 27908981; PubMed Central PMCID: PMC5295469.
  4. Wang CS, Kavalali ET, Monteggia LM. BDNF signaling in context: From synaptic regulation to psychiatric disorders. Cell. 2022 Jan 6;185(1):62–76. doi:10.1016/j.cell.2021.12.003 PubMed PMID: 34963057; PubMed Central PMCID: PMC8741740.
  5. Camuso S, La Rosa P, Fiorenza MT, Canterini S. Pleiotropic effects of BDNF on the cerebellum and hippocampus: Implications for neurodevelopmental disorders. Neurobiology of Disease. 2022 Feb 1;163:105606. doi:10.1016/j.nbd.2021.105606
  6. Li Y, Li F, Qin D, Chen H, Wang J, Wang J, et al. The role of brain derived neurotrophic factor in central nervous system. Front Aging Neurosci. 2022 Sep 8;14:986443. doi:10.3389/fnagi.2022.986443 PubMed PMID: 36158555; PubMed Central PMCID: PMC9493475.
  7. Schmahmann JD. The cerebellum and cognition. Neurosci Lett. 2019 Jan 1;688:62–75. doi:10.1016/j.neulet.2018.07.005 PubMed PMID: 29997061.
  8. Balietti M, Giuli C, Conti F. Peripheral Blood Brain-Derived Neurotrophic Factor as a Biomarker of Alzheimer’s Disease: Are There Methodological Biases? Mol Neurobiol. 2018;55(8):6661–72. doi:10.1007/s12035-017-0866-y PubMed PMID: 29330839; PubMed Central PMCID: PMC6061178.
  9. Rasmussen P, Brassard P, Adser H, Pedersen MV, Leick L, Hart E, et al. Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp Physiol. 2009 Oct;94(10):1062–9. doi:10.1113/expphysiol.2009.048512 PubMed PMID: 19666694.
  10. Fujimura H, Altar CA, Chen R, Nakamura T, Nakahashi T, Kambayashi J ichi, et al. Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Hae-most. 2002 Apr;87(4):728–34. PubMed PMID: 12008958.
  11. Zagrebelsky M, Korte M. Form follows function: BDNF and its involvement in sculpting the function and structure of synapses. Neuropharmacology. 2014 Jan;76 Pt C:628–38. doi:10.1016/j.neuropharm.2013.05.029 PubMed PMID: 23752094.
  12. Klein AB, Williamson R, Santini MA, Clemmensen C, Ettrup A, Rios M, et al. Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol. 2011 Apr;14(3):347–53. doi:10.1017/S1461145710000738 PubMed PMID: 20604989.
  13. de Lucca MS, Pimentel MEO, Raimundo CKO, Henriques BD, Moreira TR, Cardoso SA, et al. Brain-derived neurotrophic factor (BDNF) levels in children and adolescents before and after stimulant use a systematic review and metanalysis. Prog Neuropsychopharmacol Biol Psychiatry. 2023 Jul 13;125:110761. doi:10.1016/j.pnpbp.2023.110761 PubMed PMID: 37044279.
  14. Zhang J, Luo W, Li Q, Xu R, Wang Q, Huang Q. Peripheral brain-derived neurotrophic factor in attention-deficit/hyperactivity disorder: A comprehensive systematic review and meta-analysis. J Affect Disord. 2018 Feb;227:298–304. doi:10.1016/j.jad.2017.11.012
  15. El Ghamry R, El-Sheikh M, Abdel Meguid M, Nagib S, Aly El Gabry D. Plasma brain-derived neurotrophic factor (BDNF) in Egyptian children with attention deficit hyperactivity disorder. Middle East Current Psychiatry. 2021 May 7;28(1):22. doi:10.1186/s43045-021-00099-4
  16. Li H, Liu L, Tang Y, Ji N, Yang L, Qian Q, et al. Sex-specific association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and plasma BDNF with attention-deficit/hyperactivity disorder in a drug-naïve Han Chinese sample. Psychiatry Research. 2014 Jul 30;217(3):191–7. doi:10.1016/j.psychres.2014.03.011
  17. Reda M, El-Nady HG, Rabie MA, Fawzy R, Adel S, AwadAllah E, et al. Comparing brain-derived neurotrophic factor levels, intelligence and memory in clinical subtypes of attention-deficit hyperactivity disorder. Middle East Current Psychiatry. 2016;23(2):56–62.
  18. Shim SH, Hwangbo Y, Kwon YJ, Jeong HY, Lee BH, Lee HJ, et al. Increased levels of plasma brain-derived neurotrophic factor (BDNF) in children with attention deficit-hyperactivity disorder (ADHD). Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1824–8. doi:10.1016/j.pnpbp.2008.08.005 PubMed PMID: 18760321.
  19. Bilgiç A, Toker A, Işık Ü, Kılınç İ. Serum brain-derived neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 levels in children with attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry. 2017 Mar 1;26(3):355–63. doi:10.1007/s00787-016-0898-2
  20. Sahin S, Yuce M, Alacam H, Karabekiroglu K, Say GN, Salıs O. Effect of methylphenidate treatment on appetite and levels of leptin, ghrelin, adiponectin, and brain-derived neurotrophic factor in children and adolescents with attention deficit and hyperactivity disorder. International Journal of Psychiatry in Clinical Practice. 2014 Oct 1;18(4):280–7. doi:10.3109/13651501.2014.940054
  21. Scassellati C, Zanardini R, Tiberti A, Pezzani M, Valenti V, Effedri P, et al. Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit–hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry. 2014 Mar 1;23(3):173–7. doi:10.1007/s00787-013-0447-1
  22. Yurteri N, Şahin İE, Tufan AE. Altered serum levels of vascular endothelial growth factor and glial-derived neurotrophic factor but not fibroblast growth factor-2 in treatment-naive children with attention deficit/hyperactivity disorder. Nord J Psychiatry. 2019;73(4–5):302–7. doi:10.1080/08039488.2019.1625437 PubMed PMID: 31170860.
  23. Chang JPC, Mondelli V, Satyanarayanan SK, Chiang YJ, Chen HT, Su KP, et al. Cortisol, inflammatory biomarkers and neurotrophins in children and adolescents with attention deficit hyperactivity disorder (ADHD) in Taiwan. Brain Behav Immun. 2020 Aug;88:105–13. doi:10.1016/j.bbi.2020.05.017 PubMed PMID: 32418647.
  24. Cubero-Millán I, Ruiz-Ramos MJ, Molina-Carballo A, Martínez-Serrano S, Fernández-López L, Machado-Casas I, et al. BDNF concentrations and daily fluctuations differ among ADHD children and respond differently to methylphenidate with no relationship with depressive symptomatology. Psychopharmacology (Berl). 2017 Jan;234(2):267–79. doi:10.1007/s00213-016-4460-1 PubMed PMID: 27807606.
  25. Wenthur CJ. Classics in Chemical Neuroscience: Methylphenidate. ACS Chem Neurosci. 2016 Aug 17;7(8):1030–40. doi:10.1021/acschemneuro.6b00199 PubMed PMID: 27409720.
  26. Danish Health Authority. National clinical guideline for ADHD. Danish Health Authority; 2021.
  27. Groom MJ, Cortese S. Current Pharmacological Treatments for ADHD. Curr Top Behav Neurosci. 2022;57:19–50. doi:10.1007/7854_2022_330 PubMed PMID: 35507282.
  28. Palasz E, Wysocka A, Gasiorowska A, Chalimoniuk M, Niewiadomski W, Niewiadomska G. BDNF as a Promising Therapeutic Agent in Parkinson’s Disease. Int J Mol Sci. 2020 Feb 10;21(3):1170. doi:10.3390/ijms21031170 PubMed PMID: 32050617; PubMed Central PMCID: PMC7037114.
  29. Wolf D, Ayon-Olivas M, Sendtner M. BDNF-Regulated Modulation of Striatal Circuits and Implications for Parkinson’s Disease and Dystonia. Biomedicines. 2024 Aug 5;12(8):1761. doi:10.3390/biomedicines12081761 PubMed PMID: 39200225; PubMed Central PMCID: PMC11351984.
  30. Leo D, Sukhanov I, Zoratto F, Illiano P, Caffino L, Sanna F, et al. Pronounced Hyperactivity, Cognitive Dysfunctions, and BDNF Dysregulation in Dopamine Transporter Knock-out Rats. J Neurosci. 2018 Feb 21;38(8):1959–72. doi:10.1523/JNEUROSCI.1931-17.2018 PubMed PMID: 29348190; PubMed Central PMCID: PMC5824739.
  31. Miguel PM, Deniz BF, Confortim HD, de Almeida W, Bronauth LP, Vieira MC, et al. Methylphenidate treatment increases hippocampal BDNF levels but does not improve memory deficits in hypoxic-ischemic rats. J Psychopharmacol. 2020 Jul;34(7):750–8. doi:10.1177/0269881120913153 PubMed PMID: 32255391.
  32. Simchon Tenenbaum Y, Weizman A, Rehavi M. The Impact of Chronic Early Administration of Psychostimulants on Brain Expression of BDNF and Other Neuroplasticity-Relevant Proteins. J Mol Neurosci. 2015 Oct;57(2):231–42. doi:10.1007/s12031-015-0611-9 PubMed PMID: 26152882.
  33. Gumus C, Yazici IP, Yazici KU, Ustundag B. Increased Serum Brain-derived Neurotrophic Factor, Nerve Growth Factor, Glial-derived Neurotrophic Factor and Galanin Levels in Children with Attention Deficit Hyperactivity Disorder, and the Effect of 10 Weeks Methylphenidate Treatment. Clin Psychopharmacol Neurosci. 2022 Nov 30;20(4):635–48. doi:10.9758/cpn.2022.20.4.635 PubMed PMID: 36263639; PubMed Central PMCID: PMC9606423.
  34. Akay AP, Resmi H, Güney SA, Erkuran HÖ, Özyurt G, Sargin E, et al. Serum brain-derived neurotrophic factor levels in treatment-naïve boys with attention-deficit/hyperactivity disorder treated with methylphenidate: an 8-week, observational pretest-posttest study. Eur Child Adolesc Psychiatry. 2017 Jul;27(1):127–35. doi:10.1007/s00787-017-1022-y PubMed PMID: 28710695.
  35. Amiri A, Torabi Parizi G, Kousha M, Saadat F, Modabbernia MJ, Najafi K, et al. Changes in plasma Brain-derived neurotrophic factor (BDNF) levels induced by methylphenidate in children with Attention deficit-hyperactivity disorder (ADHD). Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:20–4. doi:10.1016/j.pnpbp.2013.07.018 PubMed PMID: 23933054.
  36. Choi SW, Bhang S, Ahn JH. Diurnal variation and gender differences of plasma brain-derived neurotrophic factor in healthy human subjects. Psychiatry Res. 2011 Apr 30;186(2–3):427–30. doi:10.1016/j.psychres.2010.07.028 PubMed PMID: 20826006.
  37. Piccinni A, Marazziti D, Del Debbio A, Bianchi C, Roncaglia I, Mannari C, et al. Diurnal variation of plasma brain-derived neurotrophic factor (BDNF) in humans: an analysis of sex differences. Chronobiol Int. 2008 Sep;25(5):819–26. doi:10.1080/07420520802387773 PubMed PMID: 18780207.
  38. Walsh JJ, Tschakovsky ME. Exercise and circulating BDNF: Mechanisms of release and implications for the design of exercise interventions. Appl Physiol Nutr Metab. 2018 Nov;43(11):1095–104. doi:10.1139/apnm-2018-0192 PubMed PMID: 29775542.
  39. Deb P, Chini A, Guha P, Rishi A, Bhan A, Brady B, et al. Dynamic regulation of BDNF gene expression by estradiol and lncRNA HOTAIR. Gene. 2024 Mar 1;897:148055. doi:10.1016/j.gene.2023.148055 PubMed PMID: 38043834.
  40. Gravesteijn E, Mensink RP, Plat J. Effects of nutritional interventions on BDNF concentrations in humans: a systematic review. Nutr Neurosci. 2022 Jul;25(7):1425–36. doi:10.1080/1028415X.2020.1865758 PubMed PMID: 33427118.
  41. DuPaul GJ, Power TJ, Anastopoulos AD, Reid R. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation. New York: Guilford Press; 1998.
  42. Szomlaiski N, Dyrborg J, Rasmussen H, Schumann T, Koch SV, Bilenberg N. Validity and clinical feasibility of the ADHD rating scale (ADHD-RS) A Danish Nationwide Multicenter Study. Acta Paediatr. 2009 Feb;98(2):397–402. doi:10.1111/j.1651-2227.2008.01025.x PubMed PMID: 18775056.
  43. Poulsen L, Jørgensen SL, Dalsgaard S, Bilenberg N. [Danish standardization of the attention deficit hyperactivity disorder rating scale]. Ugeskr Laeger. 2009 Apr 27;171(18):1500–4. PubMed PMID: 19419629.
  44. Makransky G, Bilenberg N. Psychometric properties of the parent and teacher ADHD Rating Scale (ADHD-RS): measurement invariance across gender, age, and informant. Assessment. 2014 Dec;21(6):694–705. doi:10.1177/1073191114535242 PubMed PMID: 24852496.
  45. Arildskov TW, Virring A, Lambek R, Sonuga-Barke EJS, Østergaard SD, Thomsen PH. Brief report: ADHD Rating Scale-IV (parent/caregiver-report) norms for young Danish schoolchildren. Nord J Psychiatry. 2024 Oct;78(7):644–8. doi:10.1080/08039488.2024.2388070 PubMed PMID: 39154294.
  46. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980–8. doi:10.1097/00004583-199707000-00021 PubMed PMID: 9204677.
  47. Wechsler D. Wechsler Intelligence Scale for Children, Fourth Edition (WISC-IV). 2004.
  48. Matthews VB, Aström MB, Chan MHS, Bruce CR, Krabbe KS, Prelovsek O, et al. Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase. Diabetologia. 2009 Jul;52(7):1409–18. doi:10.1007/s00125-009-1364-1 PubMed PMID: 19387610.
  49. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Archives of Disease in Childhood. 1969;44(235):291–303.
  50. Begliuomini S, Lenzi E, Ninni F, Casarosa E, Merlini S, Pluchino N, et al. Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm. J Endocrinol. 2008 May;197(2):429–35. doi:10.1677/JOE-07-0376 PubMed PMID: 18434373.
  51. Saadat F, Khosravi N, Mohammadi MR, Seif Rabiee MA, Mohammadi MR. Brain-Derived Neurotrophic Factor as a Biomarker in Children with Attention Deficit-Hyperactivity Disorder. Journal of Krishna Institute of Medical Sciences University. 2015;4(4):10–7.
  52. Sayyah H. BDNF Plasma Level in ADHD Children: Correlation to Different Symptomatology. Current Psychiatry [Egypt]. 2009;16:284–94.
  53. Wang LJ, Wu CC, Lee MJ, Chou MC, Lee SY, Chou WJ. Peripheral Brain-Derived Neurotrophic Factor and Contactin-1 Levels in Patients with Attention-Deficit/Hyperactivity Disorder. J Clin Med. 2019 Sep 2;8(9):1366. doi:10.3390/jcm8091366 PubMed PMID: 31480710; PubMed Central PMCID: PMC6780884.
  54. Sandrini L, Di Minno A, Amadio P, Ieraci A, Tremoli E, Barbieri SS. Association between Obesity and Circulating Brain-Derived Neurotrophic Factor (BDNF) Levels: Systematic Review of Literature and Meta-Analysis. Int J Mol Sci. 2018 Aug 3;19(8):2281. doi:10.3390/ijms19082281 PubMed PMID: 30081509; PubMed Central PMCID: PMC6121551.
  55. Diniz BS, Teixeira AL. Brain-derived neurotrophic factor and Alzheimer’s disease: physiopathology and beyond. Neuromolecular Med. 2011 Dec;13(4):217–22. doi:10.1007/s12017-011-8154-x PubMed PMID: 21898045.
  56. Kim BY, Lee SH, Graham PL, Angelucci F, Lucia A, Pareja-Galeano H, et al. Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer’s Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis. Mol Neurobiol. 2017 Nov;54(9):7297–311. doi:10.1007/s12035-016-0192-9 PubMed PMID: 27815832.
  57. Ng TKS, Coughlan C, Heyn PC, Tagawa A, Carollo JJ, Kua EH, et al. Increased plasma brain-derived neurotrophic factor (BDNF) as a potential biomarker for and compensatory mechanism in mild cognitive impairment: a case-control study. Aging (Albany NY). 2021 Oct 15;13(19):22666–89. doi:10.18632/aging.203598 PubMed PMID: 34607976; PubMed Central PMCID: PMC8544315.
  58. Xie B, Zhou H, Liu W, Yu W, Liu Z, Jiang L, et al. Evaluation of the diagnostic value of peripheral BDNF levels for Alzheimer’s disease and mild cognitive impairment: results of a meta-analysis. Int J Neurosci. 2020 Mar;130(3):218–30. doi:10.1080/00207454.2019.1667794 PubMed PMID: 31518516.
  59. Cavaleri D, Moretti F, Bartoccetti A, Mauro S, Crocamo C, Carrà G, et al. The role of BDNF in major depressive disorder, related clinical features, and antidepressant treatment: Insight from meta-analyses. Neurosci Biobehav Rev. 2023 Jun;149:105159. doi:10.1016/j.neubiorev.2023.105159 PubMed PMID: 37019247.
  60. Lee TH, Lee CH, Kim IH, Yan BC, Park JH, Kwon SH, et al. Effects of ADHD therapeutic agents, methylphenidate and atomoxetine, on hippocampal neurogenesis in the adolescent mouse dentate gyrus. Neurosci Lett. 2012 Aug 30;524(2):84–8. doi:10.1016/j.neulet.2012.07.029 PubMed PMID: 22841697.
  61. Küppers E, Beyer C. Dopamine regulates brain-derived neurotrophic factor (BDNF) expression in cultured embryonic mouse striatal cells. Neuroreport. 2001 May 8;12(6):1175–9. doi:10.1097/00001756-200105080-00025 PubMed PMID: 11338187.
  62. Rivera-Maya OB, Ortiz-Robles CD, Palacios-Valladares JR, Calderón-Aranda ES. Dopamine D1-Like Receptor Stimulation Induces CREB, Arc, and BDNF Dynamic Changes in Differentiated SHSY5Y Cells. Neurochem Res. 2024 Nov 27;50(1):35. doi:10.1007/s11064-024-04293-8 PubMed PMID: 39601897; PubMed Central PMCID: PMC11602804.
Language: English
Page range: 13 - 26
Published on: May 2, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2026 Maj-Brit Aastrøm, Signe Vangkilde, Julie Ertman Nørkær Lundsgaard, Thomas Habekost, published by Psychiatric Research Unit
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.